MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$198,522K
Cash and cash
equivalents
$51,688K
Prepaid expenses and
other current assets
$7,539K
Total current assets
$257,749K
Property and equipment,
net
$72,839K
Operating lease
right-of-use asset
$39,888K
Deposit placed in escrow
$23,479K
Restricted cash
$10,292K
Long-term investments
$8,043K
Other long-term
assets
$3,615K
Total assets
$415,905K
Total liabilities and
stockholders equity
$415,905K
Total stockholders
equity
$292,542K
Total liabilities
$123,363K
Accumulated deficit
-$2,010,709K
Additional paid-in capital
$2,302,753K
Lease liability,
noncurrent
$75,045K
Total current
liabilities
$32,514K
Other long-term
liabilities
$15,804K
Accumulated other
comprehensive gain (loss)
$269K
Common stock, 0.001 par
value 400,000,000...
$229K
Accrued and other
current liabilities
$28,244K
Accounts payable
$4,270K
Back
Back
Balance Sheet
source: myfinsight.com
Allogene Therapeutics, Inc. (ALLO)
Allogene Therapeutics, Inc. (ALLO)